Satin Creditcare promoter to inject US$13.6M, lifting stake to 38.3%
What's the deal? Satin CreditcareDealroom has a profile for this one. Try Dealroom →'s board has approved a plan for promoter Trishashna Holdings & Investments to inject US$13.6M (roughly $10.5 million) into the microfinance lender. The infusion runs through a preferential allotment of 38.5 lakh fully convertible warrants priced at US$3.53 each. On full conversion, the promoter's stake rises to 38.32% from 36.17%.
Why now? The company has already collected 25% of the total as an upfront payment, per its regulatory filing. The capital is meant to bolster capital adequacy, giving the lender room to expand its loan book while cushioning against defaults.
What's the endgame? The move lands alongside heavy capital activity at subsidiary Satin FinservDealroom has a profile for this one. Try Dealroom →, which raised US$88.3M through debt and equity in the fiscal first quarter. Satin Creditcare put US$16.3M of equity into that round, part of its strategy to fund the subsidiary's growth.
The numbers: The raise follows improved results. Satin Creditcare reported consolidated net profit of US$16.7M, up 172% year-on-year, while assets under management grew 28% to US$2.16B by the end of June. Credit costs fell more than 177 basis points to 3.06%, or 1.97% excluding a US$4.89M management buffer.
What could go wrong? Investors will watch whether the company keeps credit costs contained as its loan portfolio grows. The timeline for converting the remaining warrants into equity, and how the Satin Finserv funds are actually deployed, remain open questions.
The signal: A promoter re-upping quickly through convertible warrants signals confidence in the microfinance lender's recovery — and a bet that its improving asset quality can support a bigger book.
Read more: whalesbook.com
Image credit: Generated with Gemini
